[Advisory Board Italiano sulla sindrome dell'ovaio policistico (PCOS): dalle osservazioni all'esperienze cliniche sull'uso del mioinositolo (MYO) e dell'acido alfa-lipoico (ALA) per migliorare i quadri della sindrome]
1 Obstetric and Gynecologic Clinic, University of Milan, Milan, Italy - enrico.ferrazzi@unimi.it.
2 Maggiore Polyclinic Hospital, IRCCS Ca' Granda Foundation, Padiglione Mangiagalli, University of Milan, Milan, Italy - enrico.ferrazzi@unimi.it.
3 Department of Endocrinology, Diabetology and Metabolic Diseases, University Hospital of Verona, Verona, Italy.
4 Clinic of Obstetrics and Gynecology, Ambulatory of Gynecological Endocrinology, Santa Chiara Hospital, Pisa, Italy.
5 Operative Unit of Endocrinology, Department of Medical and Surgical Sciences, S. Orsola-Malpighi Polyclinic, University of Bologna, Bologna, Italy.
6 Department of Surgery, Faculty of Medicine and Surgery, University of Cagliari, Cagliari, Italy.
7 Unit of Endocrinology and Pediatric Diabetology, Department of Pediatrics, Arcispedale S. Maria Nuova, AUSL of Reggio Emilia-IRCCS, Reggio Emilia, Italy.
8 Operative Unit of Reproductive Pathophysiology and Andrology, Sandro Pertini Hospital, Rome, Italy.
9 Giorgio Pardi Maternal-Fetal Translational Research Laboratory, Buzzi Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
10 Luigi Sacco Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
11 Unit of Obstetrics and Gynecology, Department of Women's and Children's Health and of Public Health, IRCCS A. Gemelli University Polyclinic Foundation, Sacred Heart Catholic University, Rome, Italy.
12 Center of Endocrinologic Gynecology, Obstetrics and Gynecology Clinic, University of Modena and Reggio Emilia, Modena, Italy.
13 Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.